Geode Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-93,934
Closed -$3.98M 4645
2024
Q1
$3.98M Buy
93,934
+1,121
+1% +$47.5K ﹤0.01% 2823
2023
Q4
$3.88M Buy
92,813
+4,340
+5% +$181K ﹤0.01% 2832
2023
Q3
$3.34M Buy
88,473
+5,937
+7% +$224K ﹤0.01% 2848
2023
Q2
$3.13M Buy
+82,536
New +$3.13M ﹤0.01% 2946
2020
Q1
Sell
-7,650
Closed -$671K 4191
2019
Q4
$671K Sell
7,650
-10,786
-59% -$946K ﹤0.01% 3414
2019
Q3
$1.39M Buy
18,436
+2,743
+17% +$207K ﹤0.01% 3111
2019
Q2
$1.34M Buy
15,693
+4,586
+41% +$392K ﹤0.01% 3133
2019
Q1
$1.2M Buy
11,107
+3,852
+53% +$416K ﹤0.01% 3086
2018
Q4
$613K Buy
7,255
+4,018
+124% +$339K ﹤0.01% 3296
2018
Q3
$318K Buy
3,237
+398
+14% +$39.1K ﹤0.01% 3606
2018
Q2
$327K Buy
2,839
+347
+14% +$40K ﹤0.01% 3567
2018
Q1
$245K Sell
2,492
-2,406
-49% -$237K ﹤0.01% 3622
2017
Q4
$511K Sell
4,898
-30,739
-86% -$3.21M ﹤0.01% 3353
2017
Q3
$4M Buy
35,637
+398
+1% +$44.7K ﹤0.01% 2340
2017
Q2
$3.94M Buy
35,239
+4,160
+13% +$465K ﹤0.01% 2305
2017
Q1
$3.62M Buy
31,079
+2,295
+8% +$267K ﹤0.01% 2302
2016
Q4
$3.03M Sell
28,784
-603
-2% -$63.4K ﹤0.01% 2387
2016
Q3
$3.24M Buy
29,387
+3,272
+13% +$361K ﹤0.01% 2246
2016
Q2
$3.8M Buy
26,115
+12,298
+89% +$1.79M ﹤0.01% 2098
2016
Q1
$1.97K Buy
13,817
+1,008
+8% +$144 ﹤0.01% 2469
2015
Q4
$1.97M Buy
+12,809
New +$1.97M ﹤0.01% 2500
2015
Q3
Sell
-2,463
Closed -$353K 4143
2015
Q2
$353K Sell
2,463
-541
-18% -$77.5K ﹤0.01% 3357
2015
Q1
$423K Sell
3,004
-5,050
-63% -$711K ﹤0.01% 3259
2014
Q4
$1.19M Buy
8,054
+5,320
+195% +$788K ﹤0.01% 2738
2014
Q3
$420K Buy
+2,734
New +$420K ﹤0.01% 3243